跳至主要内容
临床试验/NCT00262093
NCT00262093Unknown不适用

Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2005年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1

研究概览

简要总结

The reason for having a higher incidence of preeclampsia in primiparas may involve angiogenesis imbalance in these patients.

详细描述

Primiparity is one of the main risk factors for having preeclampsia during pregnancy. Recently, sFlt-1, soluble FMS-like tyrosine kinase-1, has been shown to be a major molecule involved in the pathogenesis of preeclampsia. Higher sFlt-1 mRNA, higher serum levels of sFlt-1 as well as lower PlGF, placental growth factor, have been found in preeclamptic patients.

We intend to check the angiogenesis profile of primiparas as compared to multiparas.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Other

入排标准

性别
Female
接受健康志愿者

入选标准

  • Every delivery

排除标准

  • Preeclampsia or pregnancy induced hypertension

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验